Skip to content
OpenCapital
Get started

Rocket Pharmaceuticals RCKT Q1 2026 earnings

Reported May 7, 2026 · Before market open

EPS-$0.42Miss by $0.01
Revenue estimate$4.5M
EPS estimate-$0.41

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$222.2K
EPS estimate$1.04

Versus estimates

Diluted EPS

Q1 2026-$0.42Miss by $0.01
Q4 2025-$0.38Beat by $0.04Q3 2025-$0.45Beat by $0.03Q2 2025-$0.59Miss by $0.02Q1 2025-$0.56Beat by $0.03Q4 2024-$0.62Beat by $0.06

Ask the moment Rocket Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Rocket Pharmaceuticals report Q1 2026 earnings?
Rocket Pharmaceuticals (RCKT) reported Q1 2026 earnings on May 7, 2026 before market open.
What were Rocket Pharmaceuticals's Q1 2026 revenue and EPS?
Rocket Pharmaceuticals reported eps of $-0.42 for Q1 2026.
Did Rocket Pharmaceuticals beat estimates in Q1 2026?
EPS missed the consensus estimate of $-0.41 by $0.01.
How did Rocket Pharmaceuticals's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 25.0% from $-0.56.
Where can I find Rocket Pharmaceuticals's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001140361-26-019573) and the 10-Q periodic report (0001193125-26-211873) directly on SEC EDGAR. The filing index links above go to sec.gov.